John Crumpler's Net Worth

$0

Estimate Recalculated Nov 5, 2024 02:08PM EST

Who is John Crumpler?

John Crumpler does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include PhaseBio Pharmaceuticals Inc, Clearside Biomedical, Inc., and G1 Therapeutics, Inc..

SEC CIK

John Crumpler's CIK is 0001674107

Past Insider Trading and Trends

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

PhaseBio Pharmaceuticals Inc (PHASQ) Snapshot price: $0.000001

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
2.46M
$5.00
—
2.46M
Oct 22
Form 3
—
0
—
—
0
No matching records found

Clearside Biomedical, Inc. (CLSD) Snapshot price: $0.9799

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-1.42%
-29.66K
$8.63
-$255,784.88
2.06M
Jan 17 - Jan 19
Form 4
-1.42%
-25.30K
$8.63
-$218,222.36
1.76M
Jan 17 - Jan 19
Form 4
+3,082.66%
1.73M
$6.41
-$483.00
1.78M
Jun 7
Form 4
+3,630.78%
2.03M
$6.83
-$483.00
2.09M
Jun 7
Form 3
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found

G1 Therapeutics, Inc. (GTHX) Snapshot price: $7.12

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-19.81%
-800.00K
$48.00
-$38,400,000.00
3.24M
May 30
Form 4
-0.92%
-37.50K
$51.11
-$1,916,677.56
4.04M
May 21 - May 23
Form 4
-2.36%
-98.52K
—
—
4.08M
Nov 30
Form 4
∞
4.17M
$15.00
—
4.17M
May 22
No matching records found